The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
A pan-cancer single-cell panorama of human natural killer cells
Open accessAbstract
dendritic cells, appear to mediate the regulation of NK cell anti-tumor immunity. Our study provides insights into NK-cell-based cancer immunity and highlights potential clinical utilities of NK cell subsets as therapeutic targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
SCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881
Scenic: single-cell regulatory network inference and clustering.
Aibar, S., González-Blas, C. B., Moerman, T., Huynh-Thu, V. A., Imrichova, H., Hulselmans, G., Rambow, F., Marine, J.-C., Geurts, P., Aerts, J., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4463 · Cited by 6,520 · cited 2×
“We then identified activated regulons for both tumor-infiltrating CD56brightCD16lo and CD56dim CD16hi NK cell subsets using SCENIC.49 Importantly, the tumor-enriched c6-DNAJB1 subset exhibitedmuch higher expression of transcription factors such as KLF6 and EGR3, which are associated with the inhibition of cytotoxicity…”
BackgroundA guide to cancer immunotherapy: from T cell basic science to clinical practice
Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154
La Manno, G., Soldatov, R., Zeisel, A., Braun, E., Hochgerner, H., Petukhov, V., Lidschreiber, K., Kastriti, M. E., Lönnerberg, P., Furlan, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0414-6 · Cited by 4,118
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z., Beiman, M., Dassa, L., Achdout, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903474106 · Cited by 3,524
Efremova, M., Vento-Tormo, M., Teichmann, S. A., & Vento-Tormo, R. (2020) · Nature Protocols · doi:10.1038/s41596-020-0292-x · Cited by 3,449
Generalizing RNA velocity to transient cell states through dynamical modeling
Bergen, V., Lange, M., Peidli, S., Wolf, F. A., & Theis, F. J. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0591-3 · Cited by 2,951
Scrublet: computational identification of cell doublets in single-cell transcriptomic data
Wolock, S. L., Lopez, R., & Klein, A. M. (2019) · Cell Systems · doi:10.1016/j.cels.2018.11.005 · Cited by 2,758
Scrublet: computational identification of cell doublets in single-cell transcriptomic data
Wolock, S. L., Lopez, R., & Klein, A. M. (2018) · doi:10.1101/357368 · Cited by 2,758
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 459
Chu, C., Lu, B., Fu, W., Li, M., Dong, K., Lyu, D., Yao, Y., Li, Y., Liu, Y., Pan, X., et al. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01806-9 · Cited by 3
“Last but not least, we also evaluate the expressions of DNAJB4 in different subtypes of myeloid cell, T cell, and NK cell based on Zemin Zhang et al.’s studies (http:// panmy eloid. cancer ‐ pku. cn/,http://pan ‐ nk.cancer ‐ pku.cn/, http://cancer ‐ pku.cn: 3838/ PanCT/) [22–24].”
Zhang, Y., He, J., Li, X., Han, Z., Chen, H., Yang, Z., & Wang, Y. (2025) · Immunologic Research · doi:10.1007/s12026-025-09665-y · Cited by 3
“It has been extensively used to study immune cell populations, track changes in gene expression during development and disease progression [30–32].”
Zhang, J., Li, M., Yang, Y., Guo, P., Li, W., An, H., Cui, Y., Guo, L., Duan, M., Lu, Y., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18101492 · Cited by 3
“In contrast, single-cell RNA sequencing (scRNA-seq) enables the dissection of individual cellular transcriptomes within heterogeneous tissues [25–27].”
Qin, W. D., Liang, G., zeng, R., Li, Y., Hong, A., Wang, H., Feng, S., Wang, Y., & Wang, Y. (2025) · Advanced Science · doi:10.1002/advs.202512620 · Cited by 8
Innate immunity in tumors: roles and therapeutic targets
Leng, S., Ren, Y., Tian, Y., Zhao, W., Mou, Y., Chen, X., Zhou, H., & Wang, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1689714 · Cited by 4
Single‐Cell RNA Sequencing of Thyroid Tissues Reveals Pathogenesis of Graves' Disease
Zhou, X., Cong, J., Peng, R., Yang, D., Dong, C., Xie, J., Yan, J., Kuang, J., Li, F., Yeap, L.-S., et al. (2025) · Advanced Science · doi:10.1002/advs.202508449 · Cited by 4
Li, X., Qin, Y., Gao, P., Wang, H., Liu, Y., Ren, L., Wu, D., & Heng, X. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s553018 · Cited by 4
Inflammation-driven prognostic model and immune landscape profiling in osteosarcoma
Zhang, R., Zhou, X., & Shen, C. (2025) · Discover Oncology · doi:10.1007/s12672-025-03691-w · Cited by 3
Single-cell atlas of the tumor immune microenvironment across syngeneic murine models
Wang, J., Jiang, B., Deng, M., Yan, H., Zhang, P., Jin, W., & Shen, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1676581 · Cited by 4
A comparative review of single-cell atlases: mapping cellular diversity across species and tissues
Look, K., Goh, P. E., Ming, L. C., Law, S. H., Tan, S. L., Tan, E. W., Ser, H. L., & Goh, B. H. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05952-x · Cited by 3
Engineering natural killer cell-derived extracellular vesicles for disease therapy
Zhang, W., Zhang, X., Zhou, Z., Xiao, L., Cheng, T., Xu, W., Xu, W., Tao, Z., Qian, H., & Shi, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114535 · Cited by 4
Comprehensive multi‐omics mapping of immune perturbations in autism spectrum disorder
Yan, C., Feng, F., Lan, C., Luo, G., Jiang, X., Wang, H., Chen, Y., Yang, Y., Deng, L., Huang, X., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70552 · Cited by 3
Dai, J., Yan, H., Chen, Y., Zhang, Y., Ruan, Z., Ruan, Z., Tian, F., Qin, H., Xu, Q., Wang, J., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07408-z · Cited by 3
“Immune cell deconvolution analysis revealed a higher abundance of immune cell subsets, including T cells [41], NK cells [40], and DCs [23, 42], in the long-survival group compared with the short-survival group (Figure S2).”
Shao, Z., Wang, X., Zhu, H. J., Yao, L., Zhang, Q., Zhai, Z., Lv, X., Xia, X., Zhang, Y., Lu, X., et al. (2026) · Advanced Science · doi:10.1002/advs.202512952 · Cited by 3
“Another large-scale pan-cancer single-cell analysis of NK cells demonstrated that those with elevated heat shock program exhibit diminished cytotoxic potential and increased expression of immune checkpoint molecules, enriched within tumors as tumor-associated NK cells [ 18 ].”
Cui, X., Zhang, B., Zhao, J., & Tian, H. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1729588 · Cited by 4
“Current evidence suggests that mechanosensing capacity, including the expression level and functional coupling of Piezo1, may differ across these subsets; however, systematic pro fi ling of Piezo1 in human NK populations is still lacking (49).”
Qian, X., Zhang, Y., Cheng, Z., Song, H., Huang, L., Jia, B., Li, J., Wang, J., & Wu, W. (2026) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013928 · Cited by 3
“Therefore, we first isolated potential NK cells based on the positive expression of NCAM1 or KLRF1 (expression > 0) and the negative expression of CD3 genes (including CD3D , CD3G , and CD3E ) [24].”
Liu, X., Ou, K., Ma, X., Yang, W., Cao, B., Lu, J., Zhang, L., Gao, L., Wang, Q., Zhang, W., et al. (2026) · ESMO Open · doi:10.1016/j.esmoop.2025.106056 · Cited by 3
“42 Notably, these exploratory analyses of peripheral immune cells were limited by the relatively small sample size and number of available specimens, which may limit the robustness of the identified correlations.”
Targeting lncRNA-mediated networks to overcome doxorubicin resistance in cancer
Qiu, M., Wang, Z., Teng, Y., Li, M., Wu, F., & Tian, Y. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105214 · Cited by 3
Zhang, H., Shao, J., Zhao, T., Wang, Y., Shao, L., Zhu, H.-X., & Liu, J. (2026) · Human Mutation · doi:10.1155/humu/2744471 · Cited by 3
“Additionally, NK cells display potent activity against cancer stem cells (CSCs); IL-2-activated NK cells effectively target CSCs, suggesting a therapeutic strategy to prevent recurrence [39, 40].”
Meng, X., Lu, J., Zhang, Y.-X., Pu, P., Guo, X.-J., Zhu, T., Hu, Z., Yu, L., Sun, Q., Song, G., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337595 · Cited by 5
“Analysis of our and two published scRNA cohorts 20 22 revealed that NK cells predominantly express β 1-and β 2-ARs (figure 5A; online supplemental figure S5A–”
Du, X., Shi, S., & Liu, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1795143 · Cited by 3
“A 2023 single-cell data analysis of 716 patients published in Cell showed a signi fi cant correlation between the functional state of NK cells and the risk of tumor metastasis, con fi rming the clinical necessity of deeply understanding TME suppression mechanisms (60).”
Defining the rules of engagement: B cells, antibodies and cancer control
Nutt, S. L., Tellier, J., & Duarte, J. D. G. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01422-x · Cited by 5
Zhu, L., Jiang, N., & Zhang, Z. (2026) · Immunity & Inflammation · doi:10.1007/s44466-026-00043-3 · Cited by 3
“The accumulation of these tumor-associated NK (TaNK) cells with diminished effector function predicts poor prognosis and resistance to PD-1/L1 inhibitors [22].”
Koufaki, M. A., Richardson, E., Bonavita, E., Reeves, R., Moeini, A., Chiang, S., Banyard, A., Russo, M., Earnshaw, C. H., Bell, C. R., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.07.002 · Cited by 5
Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives
Li, C. C., Liu, M., Lee, H.-P., Wu, W., & Ma, L. (2024) · Seminars in Liver Disease · doi:10.1055/s-0044-1787152 · Cited by 3
Guo, Q., Yuan, M., Zhang, L., & Deng, M. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae305 · Cited by 3
“Such observation underscores the differences in NK cell composition between healthy individuals and those afflicted with tumors, corroborating prior hypotheses regarding the cytotoxicfunctionality[38,44]ofCD56-dimNKcells.”
BackgroundMethodResultNon-Coding RNAs and Innate Immune Responses in Cancer
Díaz, C. R., Hernández‐Huerta, M. T., Mayoral, L. P.-C., Villegas, M. E. A., Zenteno, E., Cruz, M. M., Mayoral, E. P., Pina-Canseco, M. D. S., Andrade, G. M., Castellanos, A., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092072 · Cited by 3
“Using single-cell RNA sequencing (scRNA-seq) technologies, previous studies found that the regulation of Natural killer cells (NK cells) antitumor activity is mediated by a specific subpopulation of myeloid LAMP3+ dendritic cells [134].”
MethodAn intraepithelial ILC1-like natural killer cell subset produces IL-13
Maddineni, S., Sharma, K., Mohammad, I., Sherman, A. R., Štěpánek, I., Shin, J. H., Bando, J. K., & Sunwoo, J. B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1521086 · Cited by 3
“2.12 Published single cell RNA sequencing (scRNAseq) dataset analysis scRNAseq datasets were derived from existing published data by Cella et al. and Tang et al. (31, 32).”
InfluentialSun, L., Huai, P., Wang, Z., Zhao, Q. S., Lin, Y., Liu, T., Xue, X., Ao, S., You, J., Sun, Y., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02300-0 · Cited by 3
“At recovery stage, DHS patients exhibited down-regulated expression of CCL4L2 (involved in recruitment of T cells to enhance immunity) 29,30 compared to dapsone-tolerant individuals, re fl ecting a negative feedback loop to maintain homeostasis.”
Yang, Y., Meng, L., Zhang, T., & Tan, J. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096372729250715050452 · Cited by 3
Meng, J., Han, M., Huang, Y., Li, L., Ju, Y., Lv, D., Chen, X., Yuan, L., & Zhang, G. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf066 · Cited by 3
Wu, H., Wang, Y., Yang, R., Liang, X., Su, Y., Ma, R., Yang, Z., Du, X., Sun, Q., Huang, Y., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-18335-0 · Cited by 3
“26 Dean et al. 28 discovered that NK cell functional impairment involves rapid reprogramming within the tumor microenvironment (TME), including the upregulation of inhibitory receptors (PDCD1, LAG3, HAVCR2, CD96), loss of key chemokines (CCL3, CCL4, CCL5), and diminished cytotoxic pathways.”
Liu, Y., Yao, Y., Yang, X., Wei, M., Lu, B., Dong, K., Lyu, D., Li, Y., Guan, W., Huang, R., et al. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.70009 · Cited by 4
Liu, C., Liu, X., Cao, P., Xin, H., Li, X., & Zhu, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1513750 · Cited by 3
“These mechanisms are known to diminish immune system activity, potentially leading to reduced responses to immunotherapy and weakened immune surveillance, allowing tumor cells to evade recognition by the immune system (78, 79).”
Qiu, J., Shen, Z., Jiang, G.-Q., & Ni, Q. (2025) · Clinical Breast Cancer · doi:10.1016/j.clbc.2025.03.012 · Cited by 3
Farkas, A. M., Youssef, D., Tran, M. A., Balan, S., Newman, J. H., Audenet, F., Anastos, H., Velazquez, L. G., Peros, A., Ananthanarayanan, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.30.591366 · Cited by 3
“…expressed a paucity of cytolytic genes, were highly activated (CD69, HLA-DRA), immature (CD56 bright signature 67 ), imprinted with tissue residency 61,68 (CD69, CXCR6, ITGA1, ITGAE, RGS1), and had higher expression of a cytokine module that included IFNG (IFNG, TNF, CCL5, XCL1/2, FLT3LG) (Figures…”
BackgroundMitri, Z. I., Creason, A., Stommel, J. M., Ozmen, T. Y., Rames, M. J., Ozmen, F., Bottomly, D., Jeong, B. Y., Lim, J. Y., Sivagnanam, S., et al. (2024) · medRxiv · doi:10.1101/2024.08.29.24312245 · Cited by 3
Yoffe, L., Bhinder, B., Kang, S. W., Zhang, H., Singh, A., Ravichandran, H., Markowitz, G. J., Martin, M., Kim, J., Zhang, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.31.630523 · Cited by 3
“NK cells have been characterized at single-cell resolution across many cancer types 58 , however, little is known about the heterogeneity and functional states of NK cells in human preinvasive nodules.”
Advances in single-cell analysis, spatial profiling, and gene editing in cancer immunogenomics
Xue, R., Cheng, J., & Zhang, N. (2025) · Holistic Integrative Oncology · doi:10.1007/s44178-024-00131-7 · Cited by 2
“Adding to this series, Zhang’ group recently performed an integrative scRNA-seq analysis on natu-ral killer (NK) cells from over 700 patients across 24 tumor types [4].”
Heterogeneity of Innate Immunity
Yu, X., & Yang, C. (2025) · Organ medicine. · doi:10.1002/orm2.70013 · Cited by 2
Wang, X., Mei, Y., Wang, X., Wu, H., Wang, R., Zhang, P., Zhang, G., Li, J., Jiang, M., Fang, X., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70461 · Cited by 3
“46 Initially, we obtained the cell-by-gene expression matrix at the single-tissue level.”
Jiang, L., Fu, L., Xiong, S., Cao, G., Mei, Y., Wu, Y., Chen, J., & Lv, Y. (2025) · Biocell · doi:10.32604/biocell.2025.068507 · Cited by 2
“For example, researchers have employed scRNA-seq to investigate [9] and have uncovered novel cellular subclusters, elucidating the complex pathophysiological mechanisms underlying cerebral tissue injury during cerebral ischemia-reperfusion. scRNA-seq facilitates a meticulous elucidation of the…”
Zhāng, P., Qiao, Z., Zhao, S., & Wu, K. (2025) · Transplant Immunology · doi:10.1016/j.trim.2025.102326 · Cited by 2
Li, B., Zhou, X., & Kalluri, R. (2025) · Advanced Science · doi:10.1002/advs.202514502 · Cited by 2
Hu, Z., Chen, Y., Yang, H., Pan, Q., Li, H., Li, S., Wang, J., Huang, Y., Huang, G., & Qu, S. (2025) · Smart Medicine · doi:10.1002/smmd.70023 · Cited by 3
“NK cell subpopulations in different developmental states are simultaneously present in the tumor, suggesting that NK cell migration to the tumor may be decoupled from NK cell maturation [49].”
Luoying, W., Xingcheng, Y., Donghang, C., Long, M., Ping, W., Zhang, L., Li, Y., Zhao, T., Hongyu, C., Wang, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1694985 · Cited by 3
Single-cell landscape of immune cells in multiple autoimmune diseases
Zhu, L. D., Sun, W., Chen, K., Liu, Z., Tang, M., Chen, J., Shi, Y., Liu, Q., Zhang, W., Wang, J., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114515 · Cited by 2
Yu, L., Jiang, Y., Liu, X., Yan, F., Yan, H. P., Xie, Y., Shi, W., Shang, Z., Du, J., & Yang, Z. (2026) · Immunology · doi:10.1111/imm.70095 · Cited by 2
“Natural killer (NK) cells occupy an important position in cancer immunosurveillance and can rapidly exert antitumour effects by activating receptors (e.g., NKG2D) that enhance cytotoxicity and cytokine secretion [7].”
Resident CD49a + CD103 + NKG2C + NK cells restrict HIV infection in human lymphoid tissue explants
Perea, D., Gonzalez, A., Gallego-Cortés, A., Sánchez-Gaona, N., Pumarola, F., Ortiz, N., Llano, I., Lorente, J., Falcó, V., Genescà, M., et al. (2026) · Science Advances · doi:10.1126/sciadv.adz1565 · Cited by 2
Qian, Z.-Y., Deng, Y., Xi, M., Zhang, X. M., Sun, H., Mao, M., Luo, X.-J., Li, M., Zhang, Q., Chen, B., et al. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-1449 · Cited by 2
You, W., Hu, C., Zhang, Y., Huang, Y., Yuan, J., Wu, C.-Y., Kong, D., Zhao, M., Han, Y., Li, S., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01925-9 · Cited by 2
“https://doi.org/10.1038/s41556-026-01925-9 Guided by these findings and prior studies linking specific NK subsets to immunotherapy outcomes 26,27 , we performed single-cell RNA-seq (scRNA-seq) on NK cells from four treatment-naive patients with HCC with heterogeneous tsMHC-I expression.”
InfluentialBorra, S., Yan, D., Welner, R. S., & Yue, Z. (2026) · Biology · doi:10.3390/biology15070588 · Cited by 2
“This organization is broadly concordant with previous high-dimensional single-cell studies that have described human NK cell continua from CD56 bright cytokine producers to CD56 dim cytotoxic and tissue-or stress-adapted subsets [28,35,50,70].”
InfluentialKong, L., Gu, S., Wang, M., Gao, L., Song, X., & Gu, J. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08237-4 · Cited by 3
“Recent studies have shown that specific immune populations, such as LAMP3 + dendritic cells, could suppress NK-cell cytotoxicity within the TME [10].”
TIGIT-targeted IL-12 fusion protein engages NK and CD8+ T cells for potent tumor immunotherapy
唐卯星, Huang, Y., Bi, J., Meng, D., Zheng, X., Peng, H., Sun, R., Ma, H., Tian, Z., Sun, H., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102876 · Cited by 2
SPP1-positive macrophages drive trastuzumab resistance in HER2-positive breast cancer
Wang, D., Li, G., Lu, Y., Du, R., He, X., Sun, J., Li, D. H., Wang, S., Liu, Y., Wang, S., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03075-9 · Cited by 2
“The gene sets of the HLA_independent inhibitor-receptor and HLA_inhibitor-receptor pathways used in the NK-cell function score are from literature reports [50], whereas the remaining pathways are from the GO and MSigDB gene sets.”
Development in the Study of Natural Killer Cells for Malignant Peritoneal Mesothelioma Treatment
Liu, Y., Wu, H., Su, Y., Wang, Y., & Li, Y. (2024) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2024.0078 · Cited by 2
“32,33 In addition to peripheral blood, NK cells are also present in lymph nodes and a variety of nonlymphoid organs, including the liver, lung, pancreas, and uterus.”
Bioinformatics analysis reveals SOD1 is a prognostic factor in lung adenocarcinoma
Gao, L., Wei, W., Ma, H., Yin, M., Yang, X., Han, R., Ohara, S., Kim, D., & Wang, G. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-1400 · Cited by 3
Dokhanchi, M., Javaherdehi, A. P., Raad, M., Khalilollah, S., Mahdavi, P., Razizadeh, M. H., & Zafarani, A. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.70079 · Cited by 2
The role of TIGIT-CD226-PVR axis in mediating T cell exhaustion and apoptosis in NSCLC
Liang, Q., Wu, L., Miao, X., Xu, J., & Zhou, Y. (2024) · APOPTOSIS · doi:10.1007/s10495-024-02052-2 · Cited by 2
Huang, S., Lai, Y., Liao, H.-T., Chang, C.-L., Ma, R.-Y., Chen, Y., Liou, Y.-H., Wu, Z., Wu, Y.-C., Liu, K., et al. (2025) · eLife · doi:10.7554/elife.99010.3 · Cited by 2
He, A., Huang, Z., Chen, X., Qi, K., Zhang, S., Li, F., Lu, H., Wang, J., Peng, J., & Song, C. (2025) · The FASEB Journal · doi:10.1096/fj.202500124 · Cited by 2
“26,27 31 The advent of scRNA-seq represents a milestone in cancer research, enabling transformative advancements in understanding tumor biology and the TME.”
Application of mass cytometry in the immune microenvironment of breast cancer
Shang, Y., Pang, Y., Liu, Y., & Wang, W. (2025) · Medical Oncology · doi:10.1007/s12032-025-02770-w · Cited by 2
“…RNA sequencing can distinguish subtle molecular changes between cell types at the single-cell level and identify cell subpopulations, cellular mRNA levels do not necessarily correspond to protein expression, making the application of proteomics necessary for single-cell analysis [111, 112].”
Rees, E., Sodi, I., Foster, K. A., Ainley, L., Lyon, E. J., Galas‐Filipowicz, D., Rahman, J., Allen, R., Kimber, J., Prabu, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.26.640356 · Cited by 2
Sun, Y., Wan, M., Kolbeinsdóttir, S., Wang, K., Khare, S., Gultekin, O., Salehi, S., Lehti, K., DasGupta, R., Foukakis, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.13.676040 · Cited by 1
Zhu, Y., Wu, X., Zhang, Y., Gu, J., Zhou, R., & Guo, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33928 · Cited by 1
“2C and D, S2A, and S2B) [54].”
Current computational methods for spatial transcriptomics in cancer biology
Mo, J., Bae, J., Saqib, J., Hwang, D., Jin, Y., Park, B. J., Park, J., & Kim, J. (2024) · Advances in cancer research · doi:10.1016/bs.acr.2024.06.006 · Cited by 2
HSF1 renders NK cells too stressed to respond
Gruper, Y., Ben‐Shmuel, A., & Scherz‐Shouval, R. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01472-1 · Cited by 1
Huang, X., You, R., Liu, F., Jian, Z., Zhou, G., Yin, H., Wu, M., Sun, T., Duan, Z., Xu, W., et al. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04028-w · Cited by 1
Li, P., Zhang, W., Wu, Q., Zhang, X., & Zheng, Z. (2025) · Endocrine Connections · doi:10.1530/ec-25-0015 · Cited by 1
“In addition, elevated levels of NK cells can improve the innate immune response against oncogenesis, leading to the favorable prognoses of patients with cancers (39).”
Inhibition of eEF-2K Enhances the Antitumor Efficacy of NK Cells
Liu, X., Liu, X., Jiang, P., Qi, X., Ma, X., Zhang, X., Proud, C. G., & Li, J. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-1001 · Cited by 1
Ding, D., Huang, G., Wang, L., Shi, K., Ying, J., Shang, W., Wang, L., Zhang, C., Jiang, M., & Shen, Y. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1622345 · Cited by 1
Yuan, Z., Chen, R., Fan, R., He, Y., Sun, S., Ji, L., Qiu, C., Wu, Z., Li, D., Zeng, Q., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115428 · Cited by 1
Tumour Single‐Cell Bioinformatics: From Immune Profiling to Molecular Dynamics
Li, J. S., Ji, Z. Z., Zhang, A. Q., Ng, C. S. H., Qiao, G., Zhang, D., Li, C., Zhang, Q., To, K., & Tang, P. M. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70783 · Cited by 1
“Further subclassification revealed several functionally distinct subtypes, such as DNAJB1 + CD56 dim CD16 hi NK cell, stressed CD56 bright NK cells, effector CD56 dim NK cells and adaptive CD56 dim NK cells [26, 29].”
InfluentialRen, Z., Li, X., Liu, P., Li, J., & Bao, S. (2025) · SAGE Open Medicine · doi:10.1177/20503121251380131 · Cited by 1
“48 A recent study by Hu et al. 50 used single-cell RNA-seq to identify ribosomal protein subunits as mediators of the inflammation-to-cancer transition in GC, validated in animal models 27 and human GC tissues.”
CCCdb: a comprehensive manually curated database for cell–cell communication in human and mouse
Xu, M., Zhang, G., Wang, X., Chen, Y., Feng, C., Guo, J., Fan, X., Liu, L., Wang, Y., Cui, T. R., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1105 · Cited by 1
“CCCs coordinate essential physiological processes, including tissue homeostasis, development, and immunity, across spatiotemporal scales in complex multicellular systems [ 5 , 6 ].”
Zhang, L., Liu, Z., Ding, Y., Sun, J., Wu, Y., Su, X., Jin, K., Zeng, H., Liu, H., Chang, Y., et al. (2025) · Cancer · doi:10.1002/cncr.70196 · Cited by 1
“Given that these dysfunctional NK cells commonly downregulate traditional exhaustion molecules and membrane receptors, 16,17 effective NK cell therapies may require context - specific modulation rather than broad activation strategies.”
InfluentialPang, J., Chen, Y., Wang, H., Tang, Y., Qi, Q., Sun, Y., Zhong, S., Luo, S., Wu, J., Xu, L., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02182-8 · Cited by 1
“A groundbreaking study published in Cell has uncovered novel mechanisms of NK cells within the TIME, identifying a previously uncharacterized sub-type, termed TaNKs [9].”
He, F., Liu, Y., Zhang, X., Zhang, R., Qiu, J., & Sijia, N. (2025) · Discover Oncology · doi:10.1007/s12672-025-03918-w · Cited by 1
“…averaged gene expression profiles from heterogeneous cell populations, scRNA-seq allows for the identification of distinct cellular subpopulations, uncovering rare cell types and revealing critical insights into cell-state transitions, lineage differentiation, and disease pathogenesis [22–24].”
Liu, M., Zhang, F.-Y., Huang, Y.-J., Jiang, Z.-H., Chen, Q.-Y., Zhang, L.-J., Hu, L.-P., & Fang, Z. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05528-2 · Cited by 1
Zhang, X., Yang, J., Niu, J., Hui, X., Kong, W., Ling, X., Su, F., & Lu, Y. (2026) · APOPTOSIS · doi:10.1007/s10495-025-02232-8 · Cited by 3
Li, G., Xiao, W., Wu, H., Liu, C., Gong, L., Zhang, H., Shao, Z., Bai, J., Xia, X., Yi, X., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68676-x · Cited by 1
“…advances in single-cell transcriptome analysis provide unprecedented opportunities to comprehensively explore the immune cells in TME at a single cellular resolution, hence, single-cell RNA sequencing (scRNA-seq) has been used to analyze tumor-in fi ltrating immune cells across cancers 14 – 19 .”
Ni, Z., Gu, J., Qiu, Q., Li, Y., Tian, Z., Liu, G., Mei, J., Yang, J., & Sun, L. (2026) · BMC Cancer · doi:10.1186/s12885-026-15652-9 · Cited by 1
“Lymphocytes, particularly CD8 + T cells and NK cells, play a crucial role in antitumor immunity, according to a tumor immunology paradigm [11, 12].”
Frutoso, M., DeJong, C. S., Shree, R. S., McCartney, S. A., & Prlic, M. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlag001 · Cited by 1
Wang, Q., Zheng, X., Zhang, Z., Hao, M., Jianwei, J., Li, J., & Zhang, H. (2026) · Discover Oncology · doi:10.1007/s12672-026-04854-z · Cited by 2
Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxia
Giorgetta, S., Cortopassi, F., Chanis, T., Ni, J., Correia, M. P., Sticht, C., Ast, V., Platten, M., Cerwenka, A., & Stojanovic, A. (2026) · iScience · doi:10.1016/j.isci.2026.115492 · Cited by 1
“Interest-ingly, these cells also showed the highest abundance of IFNG transcript in the original publication by Tang et al. 53 Similarly, the signatures repressed by HIF-1 α were enriched in mouse Hif1a-deficient NK cell infiltrating lymphomas.”
InfluentialWang, L., Qi, H., Zhang, Y., 魏国招, Pan, Z., Li, X., Ma, F., Zhang, H., Yang, R., Li, X., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08075-4 · Cited by 1
“CD56 + CD16 − NK cells were identified as CD3-negative cells expressing CD56 [36].”
Chen, F., Yu, Y., Cai, X., Lin, J., Liang, R., Kang, R., Tang, D., & Liu, J. (2026) · Advanced Science · doi:10.1002/advs.202521355 · Cited by 3
“TANK cells (CD56 dim CD16 hi C6-Dnajb1 subset) demonstrate the lowest toxicity and are associated with poor prognosis [ 74 ].”
Local cues, local killers: human natural killer cells across tissues
Niehrs, A., Zeqiraj, K., Ponzetta, A., & Björkström, N. K. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.03.009 · Cited by 2
Dong, Q., Zhang, Y., He, F., & Sun, A. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08201-2 · Cited by 1
“Consistently, Tang et al. reported that NK cells with elevated stress responses exhibit reduced cytotoxicity and impaired anti-tumor immunity [33], suggesting the immunosuppressive NK cell component in AM.”
Bridging aging and colorectal cancer: synergistic roles of inflammaging and immunosenescence
Zaongo, S. D., Yang, Q., Han, M., Xi, T., Luo, Z., Wang, X., Yang, J., & Ouyang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1792954 · Cited by 2
“SIRT1 expression promotes the release of mitochondrial DNA, leading to the formation of mitochondrion-dependent nonlethal neutrophil extracellular traps (NETs), which capture tumor cells and enhance their migration (195).”
Cytotoxic CD39 + tumor-associated NK cells respond to NKG2A blockade in lung cancer
Serger, C., Rebuffet, L., Sandholzer, M. T., Rackwitz, W., Fusi, I., Herzig, P., Brüggemann, A., Pawlow, C. A., Chichelnitskiy, E., Hajnal, D., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.aeb6645 · Cited by 3
Geng, Y., Zhang, Y., Xu, X., Wang, Y., Luo, Y., & Sun, X. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01613-z · Cited by 1
“In recent years, advances in single-cell RNA sequencing (scRNA-seq) technology have facilitated the examination of spatial distribution and transcriptional diversity of molecular function within each cell population [11].”
Zhang, Y., Zhou, X., Wei, Y. Y., Zhang, H., Zhao, Y., Tong, H., Jiang, Z., Li, G., Jiang, Y., Yin, X., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117583 · Cited by 1
Guo, W., Liu, T., Ren, R., Li, N., Zhang, W., Si, J., Piao, Y., & Hu, Y. (2026) · Cell Proliferation · doi:10.1111/cpr.70246 · Cited by 1
Histone lactylation-driven intratumoral IGFBP2+ NK cells promote tumor immune evasion
Wang, X., Hou, Z., Sun, Q., Cui, Q., Shi, G., Du, X., Liu, J., Nian, Z., Qian, Y., Huang, G., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117612 · Cited by 1
Luo, Z., Shi, H., Shan, Y., Wen, D., Lin, L., Luo, X., Xiong, L., Yu, Y., Wu, Y., Zhou, J., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02995-w · Cited by 2
Chen, P., Wu, J., Tang, S., Gong, Q., Wang, C., Wang, W., Wu, Y., Tang, T., Luo, R., Wu, Z., et al. (2026) · Research · doi:10.34133/research.1366 · Cited by 1
“Single-cell RNA sequencing (scRNA-seq) has revolutionized our comprehension of disease mechanisms by enabling the identification of rare or novel cell populations and their gene expression profiles [ 14 ].”
Liu, Y., Cao, W., Jin, Y., & Xu, W. (2026) · PLoS ONE · doi:10.1371/journal.pone.0354524 · Cited by 1
“Pan-cancer analyses have revealed intricate interactions among T cells, myeloid cells, and NK cells [37], we next examined receptor-ligand communication patterns.”
Hu, X., Wu, D., Jia, F., Zhu, S., Ke, S., Chen, D., Zhao, J., Li, L., Zhang, Y., Wang, Z., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-015147 · Cited by 1
“41 Our findings suggest that PA-derived NKG2A + γδ T cells may regulate the TME beyond direct cell-killing capacity.”
Correct stimulation of CD28H arms NK cells against tumor cells
Leau, R., Duplouye, P., Huchet, V., Nerrière‐Daguin, V., Martinet, B., Néel, M., Morin, M. E., Danger, R., Braudeau, C., Josien, R., et al. (2024) · European Journal of Immunology · doi:10.1002/eji.202350901 · Cited by 1
“The heatmap showing the expression of genes used to define immature, mature, and cytotoxic NK cells [24] highlights that NK cells from cluster 1 have a more immature profile regardless of their origin.”
Metadata
- Authors
- Tang, F., Li, J., Qi, L., Liu, D., Bo, Y., Qin, S., Miao, Y., Yu, K., Hou, W., Li, J., Peng, J., Tian, Z., Zhu, L., Peng, H., Wang, D., & Zhang, Z.
- Affiliations
- Peking University (CN)
- Capital Medical University (CN)
- Shenzhen Bay Laboratory (CN)
- University of Science and Technology of China (CN)
- Corresponding author
- Zhu, Linnan
- Peng, Hui
- Wang, Dongfang
- Zhang, Zemin
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2023-09
- Volume
- 186
- Issue
- 19
- Pages
- 4235-4251.e20
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4386034505
- Cited by
- 450
- References
- 91
- Citations by year
- 2026: 136 · 2025: 181 · 2024: 120 · 2023: 11
- FWCI
- 50.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Greater South Information System
- Funders
- National Natural Science Foundation of China (31991171, 592259205, 62203019, 81988101, 91959000, 92159305)
- Peking University
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z221100007022002)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- natural killer cells, pan-cancer, single-cell transcriptomics, NK cell subsets, cancer immunotherapy, dendritic cells, antitumor immunity
- MeSH terms
- Single-Cell Gene Expression Analysis, Dendritic Cells, Humans, Immunity, Innate, Immunotherapy, Killer Cells, Natural, Neoplasms, Myeloid Cells, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review